breast cancer - search results

Scientists have developed a multiparameter molecular classifier test allowing the identification of HER2-positive breast cancer patients that can benefit from anti-HER2 treatment only.

Pfizer and Thermo Fisher Scientific announced they will collaborate to help expand local access to NGS-based lung and breast cancer testing in more than 30 countries in Latin America, Africa, and the Middle East in areas where these tests and technologies have been limited or unavailable.

TONSL has been identified as a new target for breast cancer by researchers at Indiana University. This gene is amplified in about 20% of breast cancers, and more than 30% of metastatic cases.

The antioxidant N-acetylcysteine could help overcome resistance to alpelisib in PI3Kalpha mutated breast cancer patients.

A study by researchers at the University of Maryland School of Medicine (UMSOM) found that answers generated by ChatGPT for 25 questions related to breast cancer screening were correct 88% of the time.

The American College of Surgeons (ACS) has released a review that outlines some action points for surgeons to help reduce disparities in breast cancer care.

A study has highlighted racial differences in response to neoadjuvant chemotherapy for early-stage breast cancer, which could have a biological basis.

Obesity may spur DNA damage in the breast tissue of women with BRCA1 or BRCA2 mutations.

Reveal Genomics’ ctDNA- and machine learning-based liquid biopsy predicts response to certain therapies and survival in breast cancer study.

Allelica announced that it will work with SP BioMED to conduct a study of breast cancer polygenic risk scores (PRS) using data of known breast cancer cases found in Taiwanese biobanks.